Takeda Presents New Data Showing Mezagitamab (TAK-079) Sustained Effect on Kidney Function 18 Months After Treatment in Primary IgA Nephropathy

Takeda (TSE:4502/NYSE:TAK) today announced new interim data from the Phase 1b, open-label, proof-of-concept study of ...

Biohaven: CRL Setback For SCA But Degrader Platform Advancement Warrants 'Hold' Rating

Biohaven (BHVN) downgraded after FDA setback for VYGLXIA. Learn key risks, pipeline shifts, and what investors should watch ...

UPSC Key: Cheetah translocation pact, Climate Risk Index report, and Export Promotion mission

How is the Climate Risk Index (CRI) report relevant to the UPSC exam? What significance do topics like the GRAP-3, the ...

Vertex Pharmaceuticals Incorporated (VRTX) Presents at UBS Global Healthcare Conference 2025 Transcript

Good morning, everyone. My name is Dina Elmonshed, one of the U.S. biotech analysts here at UBS. And joining me today is the President and CEO of Vertex Pharmaceuticals, Reshma Kewalramani. Thank you ...
eLife

The titin N2A-MARP signalosome constrains muscle longitudinal hypertrophy in response to stretch

The study presents important insights into the regulation of muscle hypertrophy, regulated by Muscle Ankyrin Repeat Proteins (MARPs) and mTOR. The methods are overall solid and complementary, with ...